World Orphan Drug Congress 2012
Congress - Geneva, Switzerland
"World Orphan Drug Congress Europe is now 3-congresses in one in 2012, combining the very best of orphan and rare disease clinical development, corporate and strategic development, market access, pricing and reimbursement.
Showcasing major global trends, industry best practice, real ‘How to’ case studies and 1-2-1 partnering opportunities, this event delivers unrivalled industry participation across the whole rare disease value chain."
The 2012 World Orphan Drug Congress has three dedicated tracks that offer the level of content you need to benefit these three areas of your business:
TRACK 1 - CLINICAL DEVELOPMENT AND R&D
TRACK 2 - MARKET ACCESS, PRICING & REIMBURSEMENT
TRACK 3 - CORPORATE DEVELOPMENT AND PARTNERSHIPS
(Courtesy of http://www.terrapinn.com/2012/world-orphan-drug-congress/?pk_campaign=ops&pk_kwd=NED3007)
Thu, Nov 29, 2012 - Fri, Nov 30, 2012
Starling Geneva Hotel & Conference Center
Geneva, Switzerland
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
